APOPTOSIS AND EXPRESSION OF THE BCL-2 PROTOONCOGENE IN THE FETAL AND ADULT HUMAN KIDNEY - EVIDENCE FOR THE CONTRIBUTION OF BCL-2 EXPRESSION TO RENAL CARCINOGENESIS

被引:118
作者
CHANDLER, D
ELNAGGAR, AK
BRISBAY, S
REDLINE, RW
MCDONNELL, TJ
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC PATHOL,HOUSTON,TX 77030
[2] CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106
关键词
PROGRAMMED CELL DEATH; APOPTOSIS; ONCOGENE; KIDNEY CANCER; DEVELOPMENT;
D O I
10.1016/0046-8177(94)90248-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
bcl-2 was identified as a transcript associated with the t(14;18) and imparts resistance to apoptotic cell death. bcl-2 is normally expressed in many tissues and exhibits remarkable structural and functional conservation. Using immunohistochemical and in situ DNA labeling techniques we examined the localization of bcl-2 in the developing human kidney. bcl-2 expression was rapidly upregulated in the induced metanephrogenic mesenchymal cells that differentiate into renal vesicles and nephrons. bcl-2 expression was undetectable in uninduced mesenchyme and in the renal ampullae and associated collecting system. The distribution of apoptotic cells within the developing kidney was inversely correlated with expression of bcl-2. The localization of bcl-2 protein in the adult human kidney also was examined. bcl-2 was expressed at high levels in all renal neoplasms examined providing a potential basis for the deregulation of apoptosis in the development and progression of these tumors. © 1994.
引用
收藏
页码:789 / 796
页数:8
相关论文
共 56 条
  • [11] COLTRERA MD, 1993, APPL IMMUNOHISTO M M, V1, P193
  • [12] IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES)
    CORDELL, JL
    FALINI, B
    ERBER, WN
    GHOSH, AK
    ABDULAZIZ, Z
    MACDONALD, S
    PULFORD, KAF
    STEIN, H
    MASON, DY
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) : 219 - 229
  • [13] Daidone M. G., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P28
  • [14] ROLE OF NEUROTROPHIC FACTORS IN DEVELOPMENT
    DAVIES, AM
    [J]. TRENDS IN GENETICS, 1988, 4 (05) : 139 - 143
  • [15] Davies J, 1993, Semin Cell Biol, V4, P213, DOI 10.1006/scel.1993.1025
  • [16] COOPERATIVE INTERACTION BETWEEN C-MYC AND BCL-2 PROTOONCOGENES
    FANIDI, A
    HARRINGTON, EA
    EVAN, GI
    [J]. NATURE, 1992, 359 (6395) : 554 - 556
  • [17] IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION
    GAVRIELI, Y
    SHERMAN, Y
    BENSASSON, SA
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 119 (03) : 493 - 501
  • [18] THE N-MYC PROTO-ONCOGENE AND IGF-II GROWTH-FACTOR MESSENGER-RNAS ARE EXPRESSED BY DISTINCT CELLS IN HUMAN-FETAL KIDNEY AND BRAIN
    HIRVONEN, H
    SANDBERG, M
    KALIMO, H
    HUKKANEN, V
    VUORIO, E
    SALMI, TT
    ALITALO, K
    [J]. JOURNAL OF CELL BIOLOGY, 1989, 108 (03) : 1093 - 1104
  • [19] BCL-2 IS AN INNER MITOCHONDRIAL-MEMBRANE PROTEIN THAT BLOCKS PROGRAMMED CELL-DEATH
    HOCKENBERY, D
    NUNEZ, G
    MILLIMAN, C
    SCHREIBER, RD
    KORSMEYER, SJ
    [J]. NATURE, 1990, 348 (6299) : 334 - 336
  • [20] BCL2 PROTEIN IS TOPOGRAPHICALLY RESTRICTED IN TISSUES CHARACTERIZED BY APOPTOTIC CELL-DEATH
    HOCKENBERY, DM
    ZUTTER, M
    HICKEY, W
    NAHM, M
    KORSMEYER, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) : 6961 - 6965